Kaplan-Meier Estimates of Survival Outcomes of the 40 Study Participants
Medulloblastoma
MEDULLOBLASTOMA
The shaded areas represent 95% CIs; vertical dashed lines indicate the 6-month, 12-month, 36-month, and 60-month time points; and crosses represent censored participants. MEMMAT indicates Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial.